Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Enanta Pharmaceuticals divulges anti-hepatitis B virus agents

Oct. 21, 2016

Novel DNA vaccines against Zika virus infection enter phase I study

Oct. 21, 2016

Pivotal phase III study of letermovir meets primary endpoint

Oct. 20, 2016

ContraVir Pharmaceuticals begins enrollment of next dosing group in phase IIa trial of CMX-157

Oct. 19, 2016

Spero Therapeutics receives DoD award for anti-infective potentiator program

Oct. 19, 2016

Arisan Therapeutics presents RNA polymerase inhibitors

Oct. 19, 2016

Bavarian Nordic begins phase II study of RSV vaccine

Oct. 19, 2016

Rational Vaccines reports results from phase I trial of HSV vaccine

Oct. 19, 2016

Mutabilis discloses beta-lactamase inhibitors

Oct. 18, 2016

ZMapp beneficial but not superior to standard care in PREVAIL II Ebola virus disease trial

Oct. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....